Many drugs can pass through the placenta and cause adverse effects on the foetus. Thus, during Caesarean section for puerperas who have contraindications for intravertebral anaesthesia, the use of proper drugs that have sedative, analgesic effects on the puerperas without adverse effects on the foetus is important. In this study, we investigated the effect and placental transfer of dexmedetomidine during Caesarean section under general anaesthesia. Thirty-eight puerperas were randomly divided to receive dexmedetomidine or saline before anaesthesia induction and during the operation. The dexmedetomidine-treated parturients had lower mean arterial pressure and heart rate at the delivery and at the end of the operation. The dexmedetomidine-treated parturients also needed 5.5% less propofol and 8.4% less fentanyl than the saline-treated ones. Between the dexmedetomidinetreated and saline-treated parturients, there was no difference in the maternal artery, umbilical vein, umbilical artery blood gas analysis results and the Apgar scores at 1 and 5 min. after delivery. The placental transfer rate of dexmedetomidine was 0.76. We concluded that dexmedetomidine was effective in maintaining the haemodynamic stability in the parturients during Caesarean section under general anaesthesia without adverse neonatal effects. Dexmedetomidine can pass through the placenta with a placental transfer rate of 0.76.General anaesthetics usually have obvious effects on newborns, mainly because the sedative, analgesic drugs can pass through the placenta and produce sedation and respiratory inhibition of the foetus, which presents as decreased neonatal activity and Apgar score after delivery. In the puerperas with contraindications for intravertebral anaesthesia, such as coagulopathy, infection at the puncture site, severe back pain history, prolapse of lumber intervertebral disc and sciatica, it is important to choose proper anaesthetics to minimize the effect on the newborns. In recent years, the effect of general anaesthesia on newborns has decreased because of the use of ultra-shortacting anaesthetics, such as propofol and remifentanil. However, finding a drug that will meet the need of general anaesthesia for Caesarean section and has little effect on the neonates is highly warranted in the field of obstetric anaesthesia [1][2][3].Dexmedetomidine is a highly selective a 2 receptor (a 2 -AR) agonist, which has sedative, analgesic, antisympathetic effects and 'conscious sedation without respiratory depression' characteristics.To reduce the effect on the foetus and newborn, the anaesthetic doses are usually controlled under general anaesthesia for the Caesarean section, which causes strong stress reaction. Dexmedetomidine can effectively reduce the stress reaction during tracheal intubation and operation. It has been reported that dexmedetomidine could reduce 17% of the heart rate and 8% of the oxygen consumption during the stress response to tracheal intubation [4].Experiments in animals have shown that dexmedetomidine had no ...